Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
MediCom Oncology Clinical Pearl Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting, in under three minutes. Leading experts and academic faculty fr... more
FAQs about MediCom Oncology Clinical Pearls Podcasts:How many episodes does MediCom Oncology Clinical Pearls Podcasts have?The podcast currently has 53 episodes available.
November 30, 2017What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma?Listen as Dr. Matasar discusses survivorship care for patients who have been treated for classical Hodgkin lymphoma, including late effects of treatment....more4minPlay
November 30, 2017Second primary malignancies associated with lenalidomide maintenanceDr. Jacob Laubach discusses second primary malignancies associated with lenalidomide maintenance in the transplant and post-transplant setting....more3minPlay
November 30, 2017Impact of consolidation therapy in patients post-transplantDr. Laubach discusses the impact of consolidation therapy in patients post-transplant, referencing results of the CTN StaMINA trial....more4minPlay
October 23, 2017Bortezomib as an alternate strategy for maintenance therapy.Dr. Jacob Laubach discusses bortezomib as an alternate strategy to lenalidomide for maintenance therapy in patients with multiple myeloma....more3minPlay
October 23, 2017What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma?Listen as Dr. Matasar discusses the future role of brentuximab vedotin in patients with newly diagnosed classical Hodgkin lymphoma....more3minPlay
October 23, 2017Has MRD testing become a standard of care in multiple myeloma?Dr. Ruben Niesvizky discusses MRD testing and how it has become a standard of care in multiple myeloma, as well as future directions in MRD testing that will improve outcomes in these patients....more4minPlay
September 27, 2017The Precision Promise [SM] Initiative: What is it designed to achieve?Dr. O'Reilly provides an insightful overview of how the emerging use of precision medicine and the Precision Promise [SM] initiative will impact the new drug approval process in pancreatic cancer....more5minPlay
September 27, 2017Enasidenib in mutant-IDH2 R/R AML: Results of a phase 1 dose-escalation and expansion studyDr. Eytan Stein provides a brief update on phase 1 arms of a trial studying the effectiveness of enasidenib in patients with relapsed and refractory AML and an IDH2 mutation....more9minPlay
September 27, 2017What are the optimal imaging methods to determine extent of bone disease in newly diagnosed MM?Dr. Ruben Niesvizky discusses newer approaches for imaging in patients who have multiple myeloma with bone disease, including the benefits of combining modalities such MRI and PET scan....more4minPlay
September 27, 2017The standard of care for patients receiving lenalidomide or thalidomide who are at high risk for VTEDr. Ruben Niesvizky discusses clinical approaches to managing the risk of developing VTE in myeloma patients receiving immunomodulating agents such as lenalidomide or thalidomide....more4minPlay
FAQs about MediCom Oncology Clinical Pearls Podcasts:How many episodes does MediCom Oncology Clinical Pearls Podcasts have?The podcast currently has 53 episodes available.